Compounds > lovastatin
Page last updated: 2024-08-23

lovastatin and Angiogenesis, Pathologic

lovastatin has been researched along with Angiogenesis, Pathologic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ai, J; Bielecki, R; Casper, RF; Esfandiari, N; Gotlieb, L; Khazaei, M; Ryan, E1
Bertieri, R; Boccarelli, A; Cirulli, T; Coluccia, AM; Coluccia, M; Dammacco, F; Di Pietro, G; Giannini, T; Mangialardi, G; Ribatti, D; Scavelli, C; Vacca, A1
Bałkowiec, EZ; Czajka, A; Dabrowska, A; Feleszko, W; Giermasz, A; Jakóbisiak, M; Marczak, M; Sieberth, E1
Binda, MM; Bonfil, RD; Matar, P; Roggero, EA; Rozados, VR; Scharovsky, OG1
Feleszko, W; Mlynarczuk, I; Nowis, D1

Other Studies

5 other study(ies) available for lovastatin and Angiogenesis, Pathologic

ArticleYear
Effect of a statin on an in vitro model of endometriosis.
    Fertility and sterility, 2007, Volume: 87, Issue:2

    Topics: Adult; Angiogenesis Inhibitors; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Endometriosis; Female; Humans; Lovastatin; Neovascularization, Pathologic

2007
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:12 Pt 1

    Topics: Adult; Aged; Base Sequence; Blotting, Western; Culture Media, Conditioned; Diphosphonates; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Imidazoles; Lovastatin; Male; Middle Aged; Multiple Myeloma; Neovascularization, Pathologic; Phenotype; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Zoledronic Acid

2007
Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis.
    International journal of cancer, 1999, May-17, Volume: 81, Issue:4

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cell Transformation, Neoplastic; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Lovastatin; Lymphokines; Macrophages; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Transfection; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1999
Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma.
    Clinical & experimental metastasis, 1999, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Movement; Cholesterol; Drug Screening Assays, Antitumor; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Lymphoma; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Tumor Cells, Cultured

1999
In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor.
    FEBS letters, 2001, Aug-17, Volume: 503, Issue:2-3

    Topics: Antineoplastic Agents; Cell Division; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Neovascularization, Pathologic; Pyridines; Simvastatin; Tumor Cells, Cultured

2001